144 related articles for article (PubMed ID: 25710581)
21. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
22. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
Tong GX; Memeo L; Colarossi C; Hamele-Bena D; Magi-Galluzzi C; Zhou M; Lagana SM; Harik L; Oliver-Krasinski JM; Mansukhani M; Falcone L; Hibshoosh H; O'Toole K
Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480
[TBL] [Abstract][Full Text] [Related]
23. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
24. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.
Ozcan A; Shen SS; Hamilton C; Anjana K; Coffey D; Krishnan B; Truong LD
Mod Pathol; 2011 Jun; 24(6):751-64. PubMed ID: 21317881
[TBL] [Abstract][Full Text] [Related]
25. Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors.
Martin-Montalvo A; Lorenzo PI; López-Noriega L; Gauthier BR
Expert Opin Ther Targets; 2017 Jan; 21(1):77-89. PubMed ID: 27841034
[TBL] [Abstract][Full Text] [Related]
26. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
27. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
Schmitt AC; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
[TBL] [Abstract][Full Text] [Related]
28. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.
Koo J; Mertens RB; Mirocha JM; Wang HL; Dhall D
Mod Pathol; 2012 Jun; 25(6):893-901. PubMed ID: 22388755
[TBL] [Abstract][Full Text] [Related]
29. Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.
Kilgore MR; Bosch DE; Adamson KH; Swanson PE; Dintzis SM; Rendi MH
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):637-643. PubMed ID: 30358609
[TBL] [Abstract][Full Text] [Related]
30. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.
Tacha D; Zhou D; Cheng L
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):293-9. PubMed ID: 21285870
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
Wiseman W; Michael CW; Roh MH
Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
[TBL] [Abstract][Full Text] [Related]
33. Polyclonal PAX8 expression in carcinomas of the biliary tract - Frequent non-specific staining represents a potential diagnostic pitfall.
Zong Y; Xiong Y; Dresser K; Yang M; Bledsoe JR
Ann Diagn Pathol; 2021 Aug; 53():151762. PubMed ID: 34102541
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
[TBL] [Abstract][Full Text] [Related]
35. PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: a multi-institutional study of 182 cases using the monoclonal antibody MRQ-50.
Lai WA; Hang JF; Liu CY; Bai Y; Liu Z; Gu H; Hong S; Pyo JY; Jung CK; Kakudo K; Bychkov A
Virchows Arch; 2020 Mar; 476(3):431-437. PubMed ID: 31732814
[TBL] [Abstract][Full Text] [Related]
36. Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality.
Hu A; Li H; Zhang L; Ren C; Wang Y; Liu Y; Liu C
J Clin Pathol; 2015 Jul; 68(7):522-8. PubMed ID: 25827135
[TBL] [Abstract][Full Text] [Related]
37. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
[TBL] [Abstract][Full Text] [Related]
38. PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.
Pauzar B; Karner I; Glavas-Obrovac L; Stefanić M; Dmitrović B
Coll Antropol; 2012 Nov; 36 Suppl 2():79-82. PubMed ID: 23397760
[TBL] [Abstract][Full Text] [Related]
39. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
[TBL] [Abstract][Full Text] [Related]
40. PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
Morgan EA; Pozdnyakova O; Nascimento AF; Hirsch MS
Histopathology; 2013 Feb; 62(3):406-13. PubMed ID: 23163626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
